Published in Gut on September 01, 2007
The myosin superfamily at a glance. J Cell Sci (2012) 1.23
IBD candidate genes and intestinal barrier regulation. Inflamm Bowel Dis (2014) 0.92
Small GTPases of the Ras superfamily regulate intestinal epithelial homeostasis and barrier function via common and unique mechanisms. Tissue Barriers (2013) 0.90
A role for myosin IXb, a motor-RhoGAP chimera, in epithelial wound healing and tight junction regulation. Mol Biol Cell (2012) 0.85
Association analysis of genetic variants in the myosin IXB gene in acute pancreatitis. PLoS One (2013) 0.78
Association of MYO9B gene polymorphisms with inflammatory bowel disease in Chinese Han population. World J Gastroenterol (2014) 0.77
The RhoGAP activity of myosin IXB is critical for osteoclast podosome patterning, motility, and resorptive capacity. PLoS One (2014) 0.76
MYO9B gene polymorphisms are associated with the risk of inflammatory bowel diseases. Oncotarget (2016) 0.75
MYO9B polymorphisms in multiple sclerosis. Eur J Hum Genet (2009) 0.75
Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet (2005) 2.71
Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation? Gut (2005) 2.17
Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum Mol Genet (2004) 1.66
Genetic variation in myosin IXB is associated with ulcerative colitis. Gastroenterology (2006) 1.29
IBD: a family affair. Best Pract Res Clin Gastroenterol (2004) 1.29
Association of the macrophage migration inhibitory factor gene polymorphisms with inflammatory bowel disease. Gut (2007) 1.04
Association analysis of MYO9B gene polymorphisms and inflammatory bowel disease in a Norwegian cohort. Tissue Antigens (2006) 0.89
Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J Exp Med (1993) 4.09
Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet (2000) 3.44
MHC class II antigen-bearing dendritic cells in pulmonary tissues of the rat. Regulation of antigen presentation activity by endogenous macrophage populations. J Exp Med (1988) 3.21
Potential for New York mosquitoes to transmit West Nile virus. Am J Trop Med Hyg (2000) 2.99
Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation. JAMA (1997) 2.81
Quantitative measurements of T- and B-cell function in "variable" primary hypogammaglobulinaemia: evidence for a consistent B-cell defect. Clin Exp Immunol (1977) 2.62
Studies on the density, distribution, and surface phenotype of intraepithelial class II major histocompatibility complex antigen (Ia)-bearing dendritic cells (DC) in the conducting airways. J Exp Med (1991) 2.51
Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol Cell Biol (2000) 2.48
Biologically active Rep proteins of adeno-associated virus type 2 produced as fusion proteins in Escherichia coli. J Virol (1994) 2.32
Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis. EMBO J (2000) 2.21
Synovial fluid analysis for diagnosis of intercritical gout. Ann Intern Med (1999) 2.18
Involvement of poly(ADP-ribose) polymerase in base excision repair. Biochimie (1999) 2.13
Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol (2001) 2.12
Nucleotide sequence of two rasH related-genes isolated from the yeast Saccharomyces cerevisiae. Nucleic Acids Res (1984) 2.10
Factors related to the development of CMV-specific CD8+ T cell response in CMV-seropositive solid organ transplant candidates. Am J Transplant (2015) 2.08
Bile duct injury during laparoscopic cholecystectomy: myth or reality of the learning curve? Surg Endosc (2000) 2.05
Individual expression of influenza virus PA protein induces degradation of coexpressed proteins. J Virol (1995) 2.02
[Identification of gaps in the clinical patient care of asthma in Spain. Results of the OPTIMA-GEMA survey]. An Sist Sanit Navar (2016) 2.02
Genetic analysis of sliding motility in Mycobacterium smegmatis. J Bacteriol (2000) 2.02
A COMPARISON OF THE METHOD OF EXCRETION OF NEUTRAL RED AND PHENOL RED BY THE MAMMALIAN KIDNEY. J Exp Med (1930) 2.00
A simple view of the brain through a frequency-specific functional connectivity measure. Neuroimage (2007) 1.99
The translocation, folding, assembly and redox-dependent degradation of secretory and membrane proteins in semi-permeabilized mammalian cells. Biochem J (1995) 1.98
PA subunit from influenza virus polymerase complex interacts with a cellular protein with homology to a family of transcriptional activators. J Virol (2001) 1.98
EXPERIMENTAL HEMOCHROMATOSIS. J Exp Med (1918) 1.94
Monoclonal antibodies against influenza virus PB2 and NP polypeptides interfere with the initiation step of viral mRNA synthesis in vitro. J Virol (1994) 1.93
Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet (1990) 1.92
Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor. J Pharmacol Exp Ther (1999) 1.88
IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. Proc Natl Acad Sci U S A (2000) 1.86
Allergy testing in children: why, who, when and how? Allergy (2003) 1.86
Induction of protective immunity against experimental infection with malaria using synthetic peptides. Nature (1987) 1.85
Failure to deactivate in the prefrontal cortex in schizophrenia: dysfunction of the default mode network? Psychol Med (2008) 1.83
Synthesis of biologically active influenza virus core proteins using a vaccinia virus-T7 RNA polymerase expression system. J Gen Virol (1994) 1.83
Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clin Transl Oncol (2012) 1.80
A study of HIV seroprevalence in a group of homeless youth in Hollywood, California. J Adolesc Health (1997) 1.79
The amino-terminal one-third of the influenza virus PA protein is responsible for the induction of proteolysis. J Virol (1996) 1.79
International consensus on (ICON) pediatric asthma. Allergy (2012) 1.79
Inactivation of phosphofructokinase by glucagon in rat hepatocytes. J Biol Chem (1979) 1.76
Influenza virus naked RNA can be expressed upon transfection into cells co-expressing the three subunits of the polymerase and the nucleoprotein from simian virus 40 recombinant viruses. J Gen Virol (1993) 1.74
Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease. Am J Gastroenterol (2013) 1.74
The replication activity of influenza virus polymerase is linked to the capacity of the PA subunit to induce proteolysis. J Virol (2000) 1.69
STAT3 locus in inflammatory bowel disease and multiple sclerosis susceptibility. Genes Immun (2010) 1.66
Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors. EMBO J (2001) 1.65
Influenza virus infection causes specific degradation of the largest subunit of cellular RNA polymerase II. J Virol (2007) 1.64
Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study. Aliment Pharmacol Ther (2011) 1.63
Changes in IgM and IgG antibody concentrations in brucellosis over time: importance for diagnosis and follow-up. J Infect Dis (1989) 1.62
Direct measurement of antibody affinity distribution by hapten-inhibition enzyme immunoassay. Mol Immunol (1984) 1.61
Dichotomy between immunoglobulin synthesis by cells in gut and blood of patients with hypogammaglobulinaemia. Lancet (1975) 1.60
Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the Spanish Group for Research on Sarcomas (GEIS) Ann Oncol (1998) 1.60
Regulation of immune response to inhaled antigen by alveolar macrophages: differential effects of in vivo alveolar macrophage elimination on the induction of tolerance vs. immunity. Eur J Immunol (1991) 1.59
Codon 178 mutation in ethnically diverse Creutzfeldt-Jakob disease families. Lancet (1991) 1.56
Involvement of Fcgamma receptor IIIA genotypes in susceptibility to rheumatoid arthritis. Arthritis Rheum (2000) 1.56
Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax (2009) 1.56
Adeno-associated virus DNA replication in vitro: activation by a maltose binding protein/Rep 68 fusion protein. J Virol (1994) 1.56
Y-stent-assisted coil embolization of anterior circulation aneurysms using two Solitaire AB devices: a single center experience. Interv Neuroradiol (2012) 1.55
A contiguous network of dendritic antigen-presenting cells within the respiratory epithelium. Int Arch Allergy Appl Immunol (1990) 1.54
High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors. Hum Gene Ther (1995) 1.52
Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease. Aliment Pharmacol Ther (2011) 1.50
The C677T polymorphism in the MTHFR gene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population. Scand J Rheumatol (2011) 1.50
EXPERIMENTS ON THE PRODUCTION OF SPECIFIC ANTISERA FOR INFECTIONS OF UNKNOWN CAUSE : III. NEPHROTOXINS: THEIR SPECIFICITY AS DEMONSTRATED BY THE METHOD OF SELECTIVE ABSORPTION. J Exp Med (1920) 1.48
The N-terminal half of the influenza virus NS1 protein is sufficient for nuclear retention of mRNA and enhancement of viral mRNA translation. Nucleic Acids Res (1997) 1.48
Successful treatment of a high-grade intraepithelial neoplasia with imiquimod, with vulvar pemphigus as a side effect. Eur J Obstet Gynecol Reprod Biol (2003) 1.47
Gastrointestinal stromal tumors. Abdom Imaging (2006) 1.46
EXPERIMENTS ON THE PRODUCTION OF SPECIFIC ANTISERA FOR INFECTIONS OF UNKNOWN CAUSE : II. THE PRODUCTION OF A SERUM EFFECTIVE AGAINST THE AGENT CAUSING A CHICKEN SARCOMA. J Exp Med (1919) 1.46
[D/D genotype of the gene for angiotensin converting enzyme as a risk factor for post-stent coronary restenosis]. Rev Esp Cardiol (1999) 1.46
[HFE gene mutations, hepatic iron content, and histological severity in hepatitis C virus-induced chronic hepatitis]. Rev Esp Enferm Dig (2003) 1.46
Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. Allergy (2010) 1.45
Interferon-induced psoriasis in a patient with chronic hepatitis C. Dermatology (1993) 1.45
Association of NOD2/CARD15 mutations with previous surgical procedures in Crohn's disease. Rev Esp Enferm Dig (2005) 1.44
Mutational analysis of the influenza virus A/Victoria/3/75 PA protein: studies of interaction with PB1 protein and identification of a dominant negative mutant. J Gen Virol (1996) 1.43
Studies using double mutants of the conformational transitions in influenza hemagglutinin required for its membrane fusion activity. Proc Natl Acad Sci U S A (1996) 1.43
A prospective study of a rapid method for diagnosing cytomegalovirus infections in immunosuppressed patients. Nephron (1989) 1.43
Purified allergens vs. complete extract in the diagnosis of plane tree pollen allergy. Clin Exp Allergy (2006) 1.43
Evaluation of shelf arthroplasty as a treatment for hip dysplasia in dogs. J Am Vet Med Assoc (1996) 1.43
NOD2/CARD15: geographic differences in the Spanish population and clinical applications in Crohn's disease. Rev Esp Enferm Dig (2010) 1.42
[Thirty-six year old male patient with dysphonia refractory to conventional medical treatment]. Enferm Infecc Microbiol Clin (2001) 1.42
The mechanisms of action of lithium. I. Effects on serotoninergic and noradrenergic systems in normal subjects. Arch Gen Psychiatry (1991) 1.42
[The prevalence of anti-HCV positivity among blood donors in Asturias. A clinical-epidemiologic study]. Med Clin (Barc) (1994) 1.41
[Sleep apnea syndrome and cerebral infarction]. Neurologia (2000) 1.41
Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis. Mol Endocrinol (2000) 1.41
Activation of phospholipid methyltransferase by glucagon in rat hepatocytes. J Biol Chem (1980) 1.41
Manometry and 24-hour ambulatory pH monitoring at two levels of the esophagus in patients with and without esophagitis. Rev Esp Enferm Dig (1998) 1.40
[Detection and molecular staging of bladder cancer using real-time RT-PCR for gelatinases (MMP-2, MMP-9) and TIMP-2 in peripheral blood]. Actas Urol Esp (2011) 1.40
Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 1.40
[Optimizing treatment of complicated forms of inflammatory bowel disease. Fistulizing Crohn's disease]. An Med Interna (2003) 1.39
[Adalimumab induction and maintenance therapy for Crohn's disease. An open-label study]. Rev Esp Enferm Dig (2008) 1.39
[Determination of colonic transit time in healthy subjects in Mexico City. Prospective study]. Rev Gastroenterol Mex (2006) 1.39
THE LURE OF MEDICAL HISTORY: CLAUDE BERNARD. Cal West Med (1928) 1.39
[Strength of inspiratory muscles in chronic heart failure and chronic pulmonary obstructive disease]. Rev Med Chil (2001) 1.39